U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems
Go back to U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems| Abbott Laboratories (NYSE: ABT) | Delayed: 90.26 +2.43 (2.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.83 | 52 Week High | $46.38 | |||
| Open | $88.95 | 52 Week Low | $36.00 | |||
| Day High | $90.93 | P/E | 60.17 | |||
| Day Low | $88.73 | EPS | $1.50 | |||
| Volume | 8,765,073 | |||||
